Sun Bioscience, founded in 2016, is a pioneer in Precision Health, aiming to revolutionize personalized medicine by leveraging patient stem cells to identify effective drugs. Their proprietary Gri3D platform enables the automated, robust, and scalable generation of standardized organoids, including retinal, intestinal, cerebral, pancreatic, otic, and liver organoids. Academic collaborators and global corporations trust Sun Bioscience's technology to standardize their organoid cultures, facilitating drug development and advancing research in various fields.
Paul Joseph Dyson, Irina Sinenko, Roland Christopher Turnell-Ritson